StockNews.com Initiates Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
Equities research analysts at StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Shares of NASDAQ EIGR opened at $6.74 on Friday. The firm has a market cap […]
More Stories
Biden Awards 7 Veterans With Medal of Honor, 8 First Responders With Medal of Valor
By Jacob Burg President Joe Biden on Jan. 3 awarded seven Korean and Vietnam War veterans with the Medal of...
Sedentary Lifestyle Linked to Higher Risk of 19 Health Conditions: Study
By Naveen Athrappully People who lead a sedentary life, uncommitted to physical exercise, face a higher risk of various health...
Stria Lithium (CVE:SRA) Share Price Passes Below 200-Day Moving Average – Here’s What Happened
Stria Lithium Inc. (CVE:SRA – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday...
Congress Prepares to Certify Trump’s Election Victory on Jan. 6
By Tom Ozimek Congress will hold a joint session on Jan. 6 to count the Electoral College votes, marking the...
Omineca Mining and Metals (CVE:OMM) Stock Price Down 14.3% – What’s Next?
Omineca Mining and Metals Ltd. (CVE:OMM – Get Free Report) shares dropped 14.3% during mid-day trading on Saturday . The...
Stalled Minnesota Copper-Nickel Mine Could Break Ground With Trump Back in White House
By John Haughey A fiercely contested Minnesota copper-nickel mining proposal is among stymied mineral and energy development projects President-elect Donald...